{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:10:45Z","timestamp":1784333445423,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015003","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"reference-count":304,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015003.pub2","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:27:32Z","timestamp":1739168852000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Colchicine for the primary prevention of cardiovascular events"],"prefix":"10.1002","volume":"2025","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro Asociado Cochrane Ecuador, Centro de Investigaci\u00f3n en Salud P\u00fablica y Epidemiolog\u00eda Cl\u00ednica (CISPEC), Quito, Ecuador; Universidad UTE; Quito Ecuador"},{"name":"Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain"},{"name":"C\u00e1tedra Rectoral de Medicina Basada en la Evidencia; Universidad de Carabobo; Valencia Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A","family":"Gemmato-Valecillos","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYC Health + Hospitals \/ Elmhurst; Icahn School of Medicine at Mount Sinai; New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Monge Mart\u00edn","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Bautista","family":"De Sanctis","sequence":"additional","affiliation":[{"name":"The Institute of Molecular and Translational Medicine; Palacky University Olomouc, Faculty of Medicine and Dentistry; Olomouc Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Elena","family":"Mart\u00ed-Amarista","sequence":"additional","affiliation":[{"name":"Jencare Senior Medical Center; Geriatric Medicine Department; Berwyn Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Hidalgo","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro Asociado Cochrane Ecuador, Centro de Investigaci\u00f3n en Salud P\u00fablica y Epidemiolog\u00eda Cl\u00ednica (CISPEC), Quito, Ecuador.; Universidad UTE; Quito Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Alegr\u00eda-Barrero","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J","family":"Riera Lizardo","sequence":"additional","affiliation":[{"name":"C\u00e1tedra Rectoral de Medicina Basada en la Evidencia; Universidad de Carabobo; Valencia Venezuela"},{"name":"Medicine Department, Rheumatology Unit; Universidad de Carabobo; Valencia Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Correa-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain"},{"name":"Department of Hospital Pharmacy and Medical Devices; Hospital Central de la Defensa G\u00f3mez Ulla; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/ejcts\/ezx401","article-title":"The effect of colchicine administration on postoperative pleural effusion following lung resection: a randomized blinded placebo-controlled feasibility pilot study","volume":"54","author":"Agzarian","year":"2018","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejcts\/ezx422","article-title":"Colchicine for prevention of perioperative atrial fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study","volume":"53","author":"Bessissow","year":"2018","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0003|cit3","first-page":"968","article-title":"A randomized double-blind controlled trial of colchicine in primary biliary cirrhosis","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0004|cit4","first-page":"1172","article-title":"Colchicine therapy in primary biliary cirrhosis","volume":"6","author":"Bodenheimer","year":"1986","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Schaffner","year":"1988","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015003.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/0168-8278(89)90200-6","article-title":"Randomized controlled clinical trial of colchicine in the long term treatment of liver cirrhosis","volume":"9","author":"Buligescu","year":"1989","journal-title":"Journal of Hepatology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD015003.pub2-BIB0007|cit7","first-page":"423A","article-title":"Lack of effect of Colchicine in alcoholic cirrhosis: final results of a double-blind randomized trial","volume":"32","author":"Cortez Pinto","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD015003.pub2-BIB0008|cit8","first-page":"A20","article-title":"Colchicine in alcoholic cirrhosis - preliminary results of a double-blind randomized trial","volume":"35","author":"Cortez Pinto","year":"1994","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00042737-200204000-00007","article-title":"Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial","volume":"14","author":"Cortez-Pinto","year":"2002","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0010|cit10","first-page":"967","article-title":"Colchicine is effective in the treatment of primary biliary cirrhosis","volume":"5","author":"Kaplan","year":"1985","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0011|cit11","first-page":"382","article-title":"A prospective trial of colchicine for primary biliary cirrhosis. (ABSTRACT)","volume":"50","author":"Kaplan","year":"1987","journal-title":"Acta Gastroenterologica Belgica"},{"issue":"23","key":"10.1002\/14651858.CD015003.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0016-5085(79)90018-0","article-title":"Treatment of cirrhosis with colchicine. A double-blind randomized trial","volume":"77","author":"Kershenobich","year":"1979","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0015|cit15","first-page":"A128\/986","article-title":"Treatment of cirrhosis with colchicine: a randomized trial","volume":"70","author":"Kershenobich","year":"1976","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1002\/14651858.CD015003.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the treatment of cirrhosis of the liver","volume":"318","author":"Kershenobich","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"7793","key":"10.1002\/14651858.CD015003.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(73)91248-8","article-title":"Colchicine and the treatment of liver cirrhosis","volume":"1","author":"Rojkind","year":"1973","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1365-2036.1996.98270000.x","article-title":"A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients","volume":"10","author":"Lin","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"issue":"68","key":"10.1002\/14651858.CD015003.pub2-BIB0020|cit20","first-page":"281","article-title":"Colchicine treatment of liver fibrosis","volume":"53","author":"Nikolaidis","year":"2006","journal-title":"Hepato-Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","article-title":"Colchicine treatment of primary sclerosing cholangitis","volume":"108","author":"Olsson","year":"1995","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015003.pub2-BIB0022|cit22","first-page":"S64","article-title":"Colchicine treatment in alcoholic liver disease. A controlled and randomized study","volume":"16","author":"Sainz","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0023|cit23","unstructured":"S\u00e1inz S Guarner C Villanueva C Ord\u00f3\u00f1ez J Enr\u00edquez J Colchicine in the treatment of the alcoholic liver disease. Controlled and randomized study Gastroenterolog\u00eda y Hepatolog\u00eda 1992 218-9"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0168-8278(94)80252-1","article-title":"A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis","volume":"21","author":"Wang","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0025|cit25","first-page":"1022","article-title":"A controlled trial of colchicine in primary biliary cirrhosis","volume":"4","author":"Warnes","year":"1984","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/ejcts\/ezx401","article-title":"The effect of colchicine administration on postoperative pleural effusion following lung resection: a randomized blinded placebo-controlled feasibility pilot study","volume":"3","author":"Agzarian","year":"2018","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/aos.12429","article-title":"Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial","volume":"93","author":"Ahmadieh","year":"2015","journal-title":"Acta Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00002093-200104000-00009","article-title":"Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease","volume":"15","author":"Aisen","year":"2001","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0032|cit32","first-page":"1239","article-title":"Failure of colchicine to improve short term survival in patients with severe alcoholic hepatitis","volume":"8","author":"Akriviadis","year":"1988","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0034|cit34","first-page":"399","article-title":"A double blind study of colchicine in Behcet's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.22088\/jbums.18.11.7","article-title":"The effect of colchicine in improving the symptoms of patients with knee osteoarthritis","volume":"18","author":"Amirpour","year":"2016","journal-title":"Journal of Babol University of Medical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0036|cit36","first-page":"168-171","article-title":"Oral cochicine in chronic plaque psoriasis","volume":"59","author":"Basak","year":"1993","journal-title":"Indian Journal of Dermatology, Venerology and Leprology"},{"issue":"12","key":"10.1002\/14651858.CD015003.pub2-BIB0037|cit37","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1590\/S0004-27492006000600006","article-title":"Colchicine in the treatment of the inflammatory phase of Graves\u2019 ophthalmopathy: a prospective and randomized trial with prednisone","volume":"69","author":"da Cunha Stamato","year":"2006","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.10455","article-title":"A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report","volume":"47","author":"Das","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"SUPPL 2","key":"10.1002\/14651858.CD015003.pub2-BIB0040|cit40","first-page":"30","article-title":"Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebocontrolled trial (COLAH)","volume":"50","author":"Davis","year":"2020","journal-title":"Internal Medicine Journal"},{"issue":"SUPPL 1","key":"10.1002\/14651858.CD015003.pub2-BIB0041|cit41","first-page":"797-8","article-title":"Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)","volume":"79","author":"Davis","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/annrheumdis-2020-eular.4040","article-title":"Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)","volume":"79","author":"Davis","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.joca.2020.11.002","article-title":"Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)","volume":"29","author":"Davis","year":"2021","journal-title":"Osteoarthritis and Cartilage"},{"issue":"16","key":"10.1002\/14651858.CD015003.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2665-9913(23)00065-6","article-title":"Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"D\u00f8ssing","year":"2023","journal-title":"Lancet Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0046|cit46","first-page":"63","article-title":"Symptom modifying effect of colchicine in patients with knee osteoarthritis","volume":"3","author":"Ediz","year":"2012","journal-title":"Journal of Clinical and Analytical Medicine"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD015003.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1164\/ajrccm.156.4.9703012","article-title":"An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network","volume":"156","author":"Fish","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000018407","article-title":"Topical colchicine therapy for actinic keratoses","volume":"200","author":"Grimaitre","year":"2000","journal-title":"Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/QAD.0000000000002845","article-title":"A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV","volume":"35","author":"Hays","year":"2021","journal-title":"AIDS"},{"issue":"9","key":"10.1002\/14651858.CD015003.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/S0735-1097(22)02622-5","article-title":"Efficacy and safety of low dose colchicine on surrogate markers of cardiovascular events in people living with HIV receiving antiretroviral therapy","volume":"79","author":"Korkerdsup","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0051|cit51","unstructured":"Lenior G Sernet-Gaudelus I Laurans M Descamps-Latschka B Scherrmann JM Duhamel JF Effect of colchicine in cystic fibrosis patients. Result of a Phase 2 therapeutical trial 24th European Cystic Fibrosis Conference 2001 June 6-9 WS3"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.joca.2018.01.026","article-title":"Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial","volume":"26","author":"Leung","year":"2018","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13063-015-0726-x","article-title":"Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial","volume":"16","author":"Leung","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/j.joca.2017.02.298","article-title":"Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial","volume":"25","author":"Leung","year":"2017","journal-title":"Osteoarthritis and Cartilage"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/oby.23341","article-title":"Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome","volume":"30","author":"Levine","year":"2022","journal-title":"Obesity"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0056|cit56","first-page":"305","article-title":"Colchicine confirmed as highly effective in disk disorders: Final results of an F.D.A.-approved double-blind study (FDA IND Number 21,807)","volume":"11","author":"Meek","year":"1990","journal-title":"Journal of Neurological and Orthopaedic Medicine and Surgery"},{"issue":"21","key":"10.1002\/14651858.CD015003.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1711\u20136","DOI":"10.1136\/heartjnl-2015-307827","article-title":"Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial","volume":"101","author":"Meurin","year":"2015","journal-title":"Heart"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"International Journal of Impotence Research"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0059|cit59","unstructured":"Colchicine for the Treatment of Osteoarthritis of the Knee (CLOAK) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03913442"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S208-S9","DOI":"10.1016\/j.joca.2022.02.279","article-title":"Colchicine for treatment of osteoarthritis of the knee (CLOAK) - a double-blind, placebo-controlled trial","volume":"30","author":"Patil","year":"2022","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Samuels J Bomfim F Toprover M Cohen R Davis C Krasnokutsky-Samuels S Colchicine for treatment of osteoarthritis of the knee (CLOAK) - a phase 2, double-blind, placebo-controlled trial Osteoarthritis and Cartilage 2020 28 Abstract # 748 S498","DOI":"10.1016\/j.joca.2020.02.781"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007632-198803000-00023","article-title":"The use of oral colchicine for low-back pain. A double-blind study","volume":"13","author":"Schnebel","year":"1988","journal-title":"Spine"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00007632-199007000-00018","article-title":"Intravenous colchicine for low-back pain: a double-blind study","volume":"15","author":"Simmons","year":"1990","journal-title":"Spine"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00384-009-0794-z","article-title":"Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial","volume":"25","author":"Taghavi","year":"2010","journal-title":"International Journal of Colorectal Disease"},{"issue":"6-7","key":"10.1002\/14651858.CD015003.pub2-BIB0065|cit65","first-page":"551","article-title":"Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0066|cit66","doi-asserted-by":"crossref","unstructured":"Wuttiputhanun T Phannajit J Susantitaphong P Eiam-Ong S Katavetin P Effects of colchicine on renal fibrosis marker in patients with CKD Journal of the American Society of Nephrology 2022 850 10.1681\/asn.2020111638","DOI":"10.1681\/ASN.20223311S1850b"},{"issue":"10413","key":"10.1002\/14651858.CD015003.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(23)01689-6","article-title":"Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial","volume":"402","author":"Conen","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD015003.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S2213-2600(22)00299-5","article-title":"Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial","volume":"10","author":"Eikelboom","year":"2022","journal-title":"Lancet. Respiratory Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0069|cit69","first-page":"207","article-title":"Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients","volume":"41","author":"Parise","year":"1995","journal-title":"Revista da Associac\u0327a\u0303o Me\u0301dica Brasileira"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0070|cit70","first-page":"257","article-title":"Treatment of fibrotic liver diseases with colchicine - Results of a double blind trial","volume":"46","author":"Reinhardt","year":"1986","journal-title":"Deutsche Zeitschrift fu\u0308r Verdauungs- und Stoffwechselkrankheiten"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0071|cit71","unstructured":"Efficacy of colchicine to prevent skin relapses in adult's IgA vasculitis https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2018-002114-13\/FR"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0072|cit72","unstructured":"The effectiveness of 1 mg\/day colchicine in the treatment of patients with ocular involvement in Behcet's Disease https:\/\/irct.behdasht.gov.ir\/trial\/2453"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0073|cit73","unstructured":"Colchicine for diabetic nephropathy trial (CDNT) https:\/\/clinicaltrials.gov\/study\/NCT02442921"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0074|cit74","unstructured":"Colchicine for amyotrophic lateral sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=Colchicine+for+amyotrophic+lateral+sclerosis+%28Co-ALS%29"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e028486","DOI":"10.1136\/bmjopen-2018-028486","article-title":"Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)","volume":"9","author":"Mandrioli","year":"2019","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0076|cit76","unstructured":"Colchicine for amyotrophic lateral sclerosis (Co-ALS) https:\/\/clinicaltrials.gov\/study\/NCT03693781"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0077|cit77","unstructured":"Impact of short-course colchicine versus placebo after pulmonary vein isolation (IMPROVE-PVI Pilot) https:\/\/clinicaltrials.gov\/study\/NCT04160117?tab=history&a=5"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0078|cit78","unstructured":"Colchicine use for primary prevention of coronary artery disease https:\/\/clinicaltrials.gov\/study\/NCT05175274"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0079|cit79","unstructured":"The efficacy and safety of colchicine combined with conventional therapy in multiple myeloma patients https:\/\/clinicaltrials.gov\/study\/NCT05802992"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1439-0272.2009.01004.x","article-title":"The most commonly altered type of Peyronie's disease deformity under oral colchicine treatment is lateral curvature that mostly shifts to the dorsal side","volume":"43","author":"Akman","year":"2011","journal-title":"Andrologia"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.5546\/aap.2018.eng.e649","article-title":"Gastrointestinal evaluation in colchicine-treated familial Mediterranean fever patients with chronic abdominal pain: cases series","volume":"116","author":"Akman","year":"2018","journal-title":"Archivos Argentinos de Pediatria"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0082|cit82","first-page":"311","article-title":"[Treatment of familial Mediterranean fever with colchicine]","volume":"163","author":"Alarc\u00f3n Zurita","year":"1981","journal-title":"Revista Clinica Espa\u00f1ola"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"e15716","DOI":"10.7759\/cureus.15716","article-title":"Comparison of incidence of myocardial infarction in patients with rheumatoid arthritis and diabetes mellitus","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"issue":"7003","key":"10.1002\/14651858.CD015003.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/ctr.12448","article-title":"Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus","volume":"28:","author":"Amanova","year":"2014","journal-title":"Clinical Transplantation"},{"issue":"96","key":"10.1002\/14651858.CD015003.pub2-BIB0086|cit86","first-page":"151","article-title":"Colchicine: serious interactions","volume":"17","year":"2008","journal-title":"Prescrire International"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11239-021-02517-0","article-title":"Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities","volume":"53","author":"Anyfanti","year":"2022","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0088|cit88","first-page":"513","article-title":"A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee","volume":"29","author":"Aran","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10557-018-6785-y","article-title":"Old drugs for new indications in cardiovascular medicine","volume":"32","author":"Arbel","year":"2018","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"7454","key":"10.1002\/14651858.CD015003.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in atherosclerosis regression","volume":"40","author":"Barrett","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s13063-018-2894-y","article-title":"New guidance to improve sample size calculations for trials: eliciting the target difference","volume":"19","author":"Bell","year":"2018","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5278-","volume-title":"Cytoskeleton","author":"Bershadsky","year":"1988"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9780470743386.ch17","volume-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Research Synthesis Methods"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/096032719601501104","article-title":"Markedly altered colchicine kinetics in a fatal intoxication: examination of contributing factors","volume":"15","author":"Borron","year":"1996","journal-title":"Human and Experimental Toxicology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","article-title":"Colchicine's role in cardiovascular disease management","volume":"44","author":"Buckley","year":"2024","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"B\u00e4ck","year":"2015","journal-title":"Nature Reviews. Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568010053622984","article-title":"Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update","volume":"4","author":"Cerquaglia","year":"2005","journal-title":"Current Drug Targets. Inflammation and Allergy."},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/cbin.10988","article-title":"Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases","volume":"42","author":"Chaldakov","year":"2018","journal-title":"Cell Biology International"},{"issue":"9683","key":"10.1002\/14651858.CD015003.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","article-title":"Avoidable waste in the production and reporting of research evidence","volume":"374","author":"Chalmers","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation andelaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/clpt.1993.161","article-title":"Colchicine disposition in human leukocytes after single and multiple oral administration","volume":"54","author":"Chappey","year":"1993","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40256-017-0226-3","article-title":"Teaching an old dog new tricks: colchicine in cardiovascular medicine","volume":"17","author":"Chen","year":"2017","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yexmp.2018.01.008","article-title":"Potential of anti-inflammatory agents for treatment of atherosclerosis","volume":"104","author":"Chistiakov","year":"2018","journal-title":"Experimental and Molecular Pathology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","article-title":"Colchicine in clinical medicine. A guide for internists","volume":"21","author":"Cocco","year":"2010","journal-title":"European Journal of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD015003.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00424-017-1941-y","article-title":"Macrophages in vascular inflammation and atherosclerosis","volume":"469","author":"Cochain","year":"2017","journal-title":"Pflugers Archiv: European Journal of Physiology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13063-014-0526-8","article-title":"Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers","volume":"16","author":"Cook","year":"2015","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.berh.2017.09.012","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"31","author":"Croca","year":"2017","journal-title":"Best Practice and Research. Clinical Rheumatology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","article-title":"Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis","volume":"19","author":"Cronstein","year":"2013","journal-title":"Journal of Clinical Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semarthrit.2012.03.013","article-title":"Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review","volume":"42","author":"Curiel","year":"2012","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-0040-1708035","article-title":"Thrombo-inflammation in cardiovascular disease: an expert consensus document from the third Maastricht consensus conference on thrombosis","volume":"120","author":"d'Alessandro","year":"2020","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11095-008-9789-7","article-title":"Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein","volume":"26","author":"Dahan","year":"2009","journal-title":"Pharmaceutical Research"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/joca.2002.0516","article-title":"A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee","volume":"10","author":"Das","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: an ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4140\/TCP.n.2013.176","article-title":"Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout","volume":"28","author":"Davis","year":"2013","journal-title":"Consultant Pharmacist"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/9781119536604.ch10","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2019"},{"issue":"20","key":"10.1002\/14651858.CD015003.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2013.08.726","article-title":"Colchicine and the heart: pushing the envelope","volume":"62","author":"Deftereos","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"e003183","DOI":"10.1161\/CIRCGEN.120.003183","article-title":"Pharmacogenomics of the efficacy and safety of colchicine in COLCOT","volume":"14","author":"Dub\u00e9","year":"2021","journal-title":"Circulation. Genomic and Precision Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"e66844","DOI":"10.1371\/journal.pone.0066844","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review","volume":"8","author":"Dwan","year":"2013","journal-title":"PLOS One"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014808","article-title":"Colchicine for the secondary prevention of cardiovascular events","author":"Ebrahimi","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/molecules26010179","article-title":"Microbiota-mediated immune regulation in atherosclerosis","volume":"26","author":"Eshghjoo","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.afjem.2019.12.005","article-title":"Colchicine overdose: A South African experience, a case report","volume":"10","author":"Essame","year":"2020","journal-title":"African Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"117954412110287","DOI":"10.1177\/11795441211028751","article-title":"Cardiovascular disease in rheumatoid arthritis: risk factors, autoantibodies, and the effect of antirheumatic therapies","volume":"14","author":"Fazeli","year":"2021","journal-title":"Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0130|cit130","unstructured":"Approval package for application number: 22-351 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022351s000_SumR.pdf"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0131|cit131","unstructured":"Approval package for application number 210942Orig1s000 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/210942Orig1s000Approv.pdf"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0132|cit132","unstructured":"Office of New Drugs (OND) Annual Report Breaking Barriers to Advance Public Health; 2023 https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/office-new-drugs-ond-annual-reports"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-021-02542-7","article-title":"Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Research and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine for the prevention of postpericardiotomy syndrome","volume":"27","author":"Finkelstein","year":"2002","journal-title":"Herz"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clinical Toxicology"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/eurheartj\/ehaa974","article-title":"Colchicine for secondary prevention in coronary disease","volume":"42","author":"Fiolet","year":"2021","journal-title":"European Heart Journal"},{"issue":"38","key":"10.1002\/14651858.CD015003.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.2174\/1381612825666190925163827","article-title":"A brief review of cardiovascular diseases, associated risk factors and current treatment regimes","volume":"25","author":"Flora","year":"2019","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"e00616","DOI":"10.1002\/prp2.616","article-title":"Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy","volume":"8","author":"Forkosh","year":"2020","journal-title":"Pharmacology Researches and Perspectives"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frosteg\u00e5rd","year":"2013","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1111\/1346-8138.15712","article-title":"Case of hypocomplementemic urticarial vasculitis with Sjogren's syndrome successfully treated with oral corticosteroid and colchicine","volume":"48","author":"Fujii","year":"2021","journal-title":"Journal of Dermatology"},{"issue":"23","key":"10.1002\/14651858.CD015003.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/sim.4282","article-title":"Principles for the ethical analysis of clinical and translational research","volume":"30","author":"Gelfond","year":"2011","journal-title":"Statistical Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1005-9","volume-title":"Encyclopedia of Behavioral Medicine","author":"Gellman","year":"2013"},{"issue":"12","key":"10.1002\/14651858.CD015003.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"111788","DOI":"10.1016\/j.ejmech.2019.111788","article-title":"Recent developments on (-)-colchicine derivatives: synthesis and structure-activity relationship","volume":"185","author":"Ghawanmeh","year":"2020","journal-title":"European Journal of Medicine and Chemistry"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5","year":"2017","journal-title":"Nature Reviews. Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1517\/13543784.2010.484018","article-title":"Investigational approaches to therapies for idiopathic pulmonary fibrosis","volume":"19","author":"Gomer","year":"2010","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004481.pub2","article-title":"Colchicine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-3754-0","volume-title":"Atherosclerosis: Cellular and Molecular Interactions in the Artery Wall","author":"Gotlieb","year":"1991"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0149|cit149","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0150|cit150","unstructured":"GraphPad Computing number needed to treat (NNT) (graphpad.com) 2024"},{"issue":"7651","key":"10.1002\/14651858.CD015003.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/10600280221148031","article-title":"Drugs that interact with colchicine via inhibition of cytochrome P450 3A4 and P-Glycoprotein: a signal detection analysis using a database of spontaneously reported adverse events (FAERS)","volume":"57","author":"G\u00f3mez-Lumbreras","year":"2023","journal-title":"Annals of Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0153|cit153","first-page":"211","article-title":"Recurrent pericardial effusion due to familiar Mediterranean fever","volume":"47","author":"Halabe-Cherem","year":"2009","journal-title":"Revista M\u00e9dica del Instituto Mexicano del Seguro Social"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.5001\/omj.2021.25","article-title":"Cardiovascular risk in rheumatoid arthritis: literature review","volume":"36","author":"Hannawi","year":"2021","journal-title":"Oman Medical Journal"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annual Review of Pathology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine drug interaction errors and misunderstandings: recommendations for improved evidence\u2011based management","volume":"46","author":"Hansten","year":"2021","journal-title":"Drug Safety"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jrsm.1239","article-title":"The albatross plot: a novel graphical tool for presenting results of diversely reported studies in a systematic review","volume":"8","author":"Harrison","year":"2017","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011047.pub2","article-title":"Colchicine for prevention of cardiovascular events","author":"Hemkens","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/clp.10.65","article-title":"Reducing residual vascular risk in patients with atherogenic dyslipidemia: where do we go from here?","volume":"5","author":"Hermans","year":"2010","journal-title":"Clinical Lipidology"},{"issue":"7414","key":"10.1002\/14651858.CD015003.pub2-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0161|cit161","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/9780470712184.ch8","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"12","key":"10.1002\/14651858.CD015003.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/rheumatology\/kez178","article-title":"Colchicine gastrotoxicity in a patient with chronic kidney disease","volume":"58","author":"Ho","year":"2019","journal-title":"Rheumatology"},{"issue":"7211","key":"10.1002\/14651858.CD015003.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/02793695-20110705-06","article-title":"What you see depends on where you're looking and how you look at it: publication bias andoutcome reporting bias","volume":"49","year":"2011","journal-title":"Journal of Psychosocial Nursing and Mental Health Services"},{"issue":"15","key":"10.1002\/14651858.CD015003.pub2-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2174\/1389201022666210122142233","article-title":"Targeting macrophages in atherosclerosis","volume":"22","author":"Hu","year":"2021","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592.","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3899\/jrheum.181236","article-title":"Vascular pathology and osteoarthritis: a systematic review","volume":"47","author":"Hussain","year":"2020","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.esxm.2019.07.003","article-title":"Evaluation of oral pentoxifylline, colchicine, and penile traction for the management of Peyronie's disease","volume":"7","author":"Ibrahim","year":"2019","journal-title":"Sexual Medicine"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1248\/bpb.b20-00314","article-title":"Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese claims database","volume":"43","author":"Imai","year":"2020","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"17","key":"10.1002\/14651858.CD015003.pub2-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD015003.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"issue":"22","key":"10.1002\/14651858.CD015003.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"Colchicine for the prevention of the post-pericardiotomy syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ahj.2011.05.017","article-title":"Colchicine prevents early postoperative pericardial and pleural effusions","volume":"162","author":"Imazio","year":"2011","journal-title":"American Heart Journal"},{"issue":"9936","key":"10.1002\/14651858.CD015003.pub2-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/fca.15.59","article-title":"Colchicine for cardiovascular medicine","volume":"12","author":"Imazio","year":"2016","journal-title":"Future Cardiology"},{"issue":"28","key":"10.1002\/14651858.CD015003.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLOS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"issue":"3-4","key":"10.1002\/14651858.CD015003.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"9912","key":"10.1002\/14651858.CD015003.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","article-title":"Increasing value and reducing waste in research design, conduct, and analysis","volume":"383","author":"Ioannidis","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","article-title":"The tubulin code and its role in controlling microtubule properties and functions","volume":"21","author":"Janke","year":"2020","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"21","key":"10.1002\/14651858.CD015003.pub2-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1381612824666180115105850","article-title":"Isolating colchicine in 19th Century: an old drug revisited","volume":"24","author":"Karamanou","year":"2018","journal-title":"Current Pharmaceutical Design"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4103\/idoj.IDOJ_362_20","article-title":"Conjunctival ulcers in Behcet's disease and response to colchicine","volume":"11","author":"Kaur","year":"2020","journal-title":"Indian Dermatology Online Journal"},{"issue":"10448","key":"10.1002\/14651858.CD015003.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0190|cit190","first-page":"721","article-title":"Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever","volume":"16","author":"Kiraz","year":"1998","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0191|cit191","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0192|cit192","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Circulation Research"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0193|cit193","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1536867X1001000307","article-title":"Metaan: random-effects meta-analysis","volume":"10","author":"Kontopantelis","year":"2010","journal-title":"Stata Journal"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1074248418778548","article-title":"The utility of anti-inflammatory agents in cardiovascular disease: a novel perspective on the treatment of atherosclerosis","volume":"23","author":"Kottoor","year":"2018","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0195|cit195","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2174\/1381612824666180116101823","article-title":"The role of colchicine in pericardial syndromes","volume":"24","author":"Lazaros","year":"2018","journal-title":"Current Pharmaceutical Design"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/9781119536604.ch4","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Lefebvre","year":"2019"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijcard.2017.08.039","article-title":"Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis","volume":"249","author":"Lennerz","year":"2017","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0198|cit198","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine - update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0199|cit199","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/ehjqcco\/qcab044","article-title":"Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden","volume":"8","author":"Li","year":"2022","journal-title":"European Heart Journal. Quality of Care and Clinical Outcomes"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0200|cit200","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1002\/jcb.27844","article-title":"Platelet-neutrophil interaction aggravates vascular in\ufb02ammation and promotes the progression of atherosclerosis by activating the TLR4\/NF-\u03baB pathway","volume":"120","author":"Liang","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0201|cit201","doi-asserted-by":"publisher","first-page":"690","DOI":"10.2174\/1381612824666180116095658","article-title":"The role of colchicine in the treatment of autoinflammatory diseases","volume":"24","author":"Liantinioti","year":"2018","journal-title":"Current Pharmaceutical Design"},{"issue":"420","key":"10.1002\/14651858.CD015003.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nature Reviews. Disease Primers"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0204|cit204","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","article-title":"Cardiovascular disease in systemic lupus erythematosus: an update","volume":"30","author":"Liu","year":"2018","journal-title":"Current Opinion in Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1161\/ATVBAHA.119.312513","article-title":"Understanding atherosclerosis through an osteoarthritis data set","volume":"39","author":"Liu","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"1175174","DOI":"10.3389\/fcvm.2023.1175174","article-title":"Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis","volume":"10","author":"Liu","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0209|cit209","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0210|cit210","doi-asserted-by":"publisher","first-page":"622862","DOI":"10.3389\/fphar.2020.622862","article-title":"Identifying and characterizing serious adverse drug reactions associated with drug-drug interactions in a spontaneous reporting database","volume":"11","author":"Magro","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0211|cit211","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","article-title":"Guidelines on the diagnosis and management of pericardial diseases executive summary; The task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology","volume":"25","author":"Maisch","year":"2004","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0212|cit212","first-page":"9","volume-title":"Randomization, Masking, and Allocation Concealment","author":"Mart\u00ed-Carvajal","year":"2018"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/1060028018765939","article-title":"The emerging role of inflammation in cardiovascular disease","volume":"52","author":"Mart\u00ednez","year":"2018","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/9781119536604.ch9","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"McKenzie","year":"2019"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0216|cit216","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.reuma.2014.09.007","article-title":"Colchicine use in isolated renal AA amyloidosis","volume":"11","author":"Meneses","year":"2015","journal-title":"Reumatologia Clinica"},{"issue":"21","key":"10.1002\/14651858.CD015003.pub2-BIB0217|cit217","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial","volume":"101","author":"Meurin","year":"2015","journal-title":"Heart"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"104033","DOI":"10.1016\/j.lpm.2020.104033","article-title":"Management of cutaneous vasculitis","volume":"49","author":"Micheletti","year":"2020","journal-title":"Presse Medicale"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41597-022-01705-8","article-title":"An agenda for addressing bias in conflict data","volume":"9","author":"Miller","year":"2022","journal-title":"Scientific Data"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0220|cit220","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2174\/0929867328666210810150940","article-title":"PCSK9 and inflammation: their role in autoimmune diseases, with a focus on rheumatoid arthritis and systemic lupus erythematosus","volume":"29","author":"Ministrini","year":"2022","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0221|cit221","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5551\/jat.7591","article-title":"Inflammation and the development of atherosclerosis","volume":"18","author":"Mizuno","year":"2011","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.clinthera.2023.08.016","article-title":"An update on inflammation in atherosclerosis: how to effectively treat residual risk","volume":"45","author":"Mohammadnia","year":"2023","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jjcc.2018.05.010","article-title":"Critical roles of inflammation in atherosclerosis","volume":"73","author":"Moriya","year":"2019","journal-title":"Journal of Cardiology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0224|cit224","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-011-4439-1","volume-title":"Concise Dictionary of Pharmacological Agents Properties and Synonyms","author":"Morton","year":"1999"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0225|cit225","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases Definition & Facts of Primary Biliary Cholangitis (Primary Biliary Cirrhosis) https:\/\/www.niddk.nih.gov\/health-information\/liver-disease\/primary-biliary-cholangitis\/all-content#section1"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0226|cit226","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0227|cit227","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11883-013-0391-z","article-title":"Colchicine for secondary prevention of cardiovascular disease","volume":"16","author":"Nidorf","year":"2014","journal-title":"Current Atherosclerosis Reports"},{"issue":"19","key":"10.1002\/14651858.CD015003.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0229|cit229","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2020.05.018","article-title":"Platelets as therapeutic targets to prevent atherosclerosis","volume":"307","author":"Nording","year":"2020","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0230|cit230","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Current Rheumatology Reports"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0231|cit231","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","article-title":"A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: clinical and therapeutic implications","volume":"309","author":"Oikonomou","year":"2020","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCULATIONAHA.121.058233","article-title":"Long-term efficacy of colchicine in patients with chronic coronary disease: insights from LoDoCo2","volume":"145","author":"Opstal","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0233|cit233","doi-asserted-by":"publisher","first-page":"e001618","DOI":"10.1136\/rmdopen-2021-001618","article-title":"Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?","volume":"7","author":"Ozen","year":"2021","journal-title":"RMD Open"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/1074248413504994","article-title":"Inflammation and atherosclerosis--revisited","volume":"19","author":"Pant","year":"2014","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1755-5922.12226","article-title":"Colchicine for prevention and treatment of cardiac diseases: a meta-analysis","volume":"35","author":"Papageorgiou","year":"2017","journal-title":"Cardiovascular Therapeutics"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1097\/MLR.0000000000001593","article-title":"Patient-centered approaches to transitional care research and implementation: overview and insights from patient-centered outcomes research institute's transitional care portfolio","volume":"59(Suppl 4)","author":"Parry","year":"2021","journal-title":"Medical Care"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0237|cit237","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1189\/jlb.1012510","article-title":"Technical advance: Inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartments","volume":"94","author":"Paschke","year":"2013","journal-title":"Journal of Leukocyte Biology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0238|cit238","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcct.2021.06.003","article-title":"Chronic inflammatory diseases and coronary heart disease: insights from cardiovascular CT","volume":"16","author":"Patel","year":"2022","journal-title":"Journal of Cardiovascular Computed Tomography"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0239|cit239","first-page":"61","article-title":"General statistical design considerations of randomized clinical trials","volume":"264","author":"Peduzzi","year":"1988","journal-title":"Progress in Clinical and Biological Research"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jclinepi.2010.12.012","article-title":"Statistically significant meta-analyses of clinical trials have modest credibility andinflated effects","volume":"64","author":"Pereira","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0241|cit241","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1681\/ASN.V74594","article-title":"Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation","volume":"7","author":"Perico","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0242|cit242","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-neutrophil crosstalk in atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0243|cit243","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.joca.2020.12.026","article-title":"Colchicine and clinical trials for hand osteoarthritis","volume":"30","author":"Plotz","year":"2022","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0244|cit244","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-57613-8_7","article-title":"Atherosclerosis","volume":"1003","author":"Rahman M","year":"2017","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0245|cit245","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00004836-200107000-00022","article-title":"Colchicine for persistent constipation after total abdominal colectomy with ileorectostomy for colonic inertia","volume":"33","author":"Rajapakse","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0246|cit246","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002148.pub2","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","author":"Rambaldi","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD015003.pub2-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.immuni.2021.07.012","article-title":"Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation","volume":"54","author":"Reglero-Real","year":"2021","journal-title":"Immunity"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0248|cit248","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"17","key":"10.1002\/14651858.CD015003.pub2-BIB0249|cit249","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1517\/14656566.2010.529432","article-title":"Colchicine for the treatment of gout","volume":"11","author":"Richette","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"25","key":"10.1002\/14651858.CD015003.pub2-BIB0250|cit250","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1016\/j.jacc.2018.06.082","article-title":"Clinician's guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week","volume":"72","author":"Ridker","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0251|cit251","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"h2463","DOI":"10.1136\/bmj.h2463","article-title":"The knowledge system underpinning healthcare is not fit for purpose and must change","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0253|cit253","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.devcel.2020.06.008","article-title":"The tubulin code in microtubule dynamics and information encoding","volume":"54","author":"Roll-Mecak","year":"2020","journal-title":"Developmental Cell"},{"issue":"12","key":"10.1002\/14651858.CD015003.pub2-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1345\/aph.1E197","article-title":"Acute colchicine intoxication during clarithromycin administration","volume":"38","author":"Rollot","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"issue":"10","key":"10.1002\/14651858.CD015003.pub2-BIB0255|cit255","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/1060028020922994","article-title":"The role of suppressing inflammation in the treatment of atherosclerotic cardiovascular disease","volume":"54","author":"Roman","year":"2020","journal-title":"Annals of Pharmacotherapy"},{"issue":"25","key":"10.1002\/14651858.CD015003.pub2-BIB0256|cit256","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"10.1002\/14651858.CD015003.pub2-BIB0257|cit257","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/CIRCULATIONAHA.120.051240","article-title":"Colchicine for secondary cardiovascular prevention in coronary disease","volume":"142","author":"Roubille","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0258|cit258","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1073\/pnas.74.8.3404","article-title":"Effects of colchicine on cyclic AMP levels in human leukocytes","volume":"74","author":"Greengard","year":"1977","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1002\/14651858.CD015003.pub2-BIB0259|cit259","first-page":"429","article-title":"Binding of colchicine and thiocolchicoside to human serum proteins and blood cells","volume":"32","author":"Sabouraud","year":"1994","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0260|cit260","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijcard.2017.04.022","article-title":"Colchicine for prevention of post-cardiac procedure atrial fibrillation: meta-analysis of randomized controlled trials","volume":"243","author":"Salih","year":"2017","journal-title":"International Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.cjca.2020.06.012","article-title":"Will colchicine soon be part of primary and secondary cardiovascular prevention?","volume":"36","author":"Samuel","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ehjqcco\/qcaa045","article-title":"Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"7","author":"Samuel","year":"2021","journal-title":"European Heart Journal. Quality of Care & Clinical Outcomes"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0263|cit263","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0265|cit265","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2020.04.018","article-title":"Platelet-leukocyte interplay during vascular disease","volume":"307","author":"Schrottmaier","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/9781119536604.ch14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2019"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0267|cit267","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6\/chapter-15"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0268|cit268","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-26782-1","volume-title":"Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis","author":"Semb","year":"2017"},{"issue":"11","key":"10.1002\/14651858.CD015003.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.cjca.2020.05.026","article-title":"Colchicine use and incident coronary artery disease in male patients with gout","volume":"36","author":"Shah","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0270|cit270","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejvs.2010.01.028","article-title":"Immunomodulation of vascular diseases: atherosclerosis and autoimmunity","volume":"39","author":"Shi","year":"2010","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0271|cit271","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.amjmed.2021.01.019","article-title":"The use of colchicine in cardiovascular diseases - a systematic review","volume":"134","author":"Siak","year":"2021","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015003.pub2-BIB0272|cit272","doi-asserted-by":"publisher","first-page":"204","DOI":"10.22037\/uj.v0i0.4198","article-title":"Long-term effect of colchicine treatment in preventing urethral stricture recurrence after internal urethrotomy","volume":"15","author":"Sinanoglu","year":"2018","journal-title":"Urology Journal"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0273|cit273","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0274|cit274","unstructured":"Stata StataCorp 2024"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0275|cit275","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0276|cit276","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Research and Therapy"},{"issue":"26","key":"10.1002\/14651858.CD015003.pub2-BIB0277|cit277","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD015003.pub2-BIB0278|cit278","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1083\/jcb.25.1.145","article-title":"The mechanism of colchicine inhibition of mitosis. I. Kinetics of inhibition and the binding of H3-colchicine","volume":"25","author":"Taylor","year":"1965","journal-title":"Journal of Cell Biology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0280|cit280","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clinthera.2018.11.014","article-title":"Colchicine in cardiovascular disease: repurposing an ancient gout drug","volume":"41","author":"Thompson","year":"2019","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","article-title":"Publication bias in meta-analysis: its causes and consequences","volume":"53","author":"Thornton","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"13","key":"10.1002\/14651858.CD015003.pub2-BIB0282|cit282","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/heartjnl-2015-309211","article-title":"Colchicine in cardiovascular disease: an ancient drug with modern tricks","volume":"102","author":"Tong","year":"2016","journal-title":"Heart"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0284|cit284","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4103\/0253-7613.144905","article-title":"Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis","volume":"46","author":"Trivedi","year":"2014","journal-title":"Indian Journal of Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0285|cit285","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2174\/1381612824666180116100310","article-title":"The role of colchicine in the prevention of cerebrovascular ischemia","volume":"24","author":"Tsivgoulis","year":"2018","journal-title":"Current Pharmaceutical Design"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0286|cit286","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ase.1671","article-title":"Academic nightmares: predatory publishing","volume":"10","author":"Van Nuland","year":"2017","journal-title":"Anatomical Sciences Education"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015003.pub2-BIB0287|cit287","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11739-011-0669-5","article-title":"The epidemiological concept of residual risk","volume":"6","author":"Vanuzzo","year":"2011","journal-title":"Internal and Emergency Medicine"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0288|cit288","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12872-015-0068-3","article-title":"Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Verma","year":"2015","journal-title":"BMC Cardiovascular Disorders"},{"issue":"9","key":"10.1002\/14651858.CD015003.pub2-BIB0289|cit289","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1023\/a:1018883731556","article-title":"Colchicine is an effective treatment for patients with chronic constipation: an open-label trial","volume":"42","author":"Verne","year":"1997","journal-title":"Digestive Diseases and Sciences"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0290|cit290","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1572-0241.2003.07417.x","article-title":"Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial","volume":"98","author":"Verne","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0291|cit291","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12603-017-0941-0","article-title":"Osteoarthristis increases the risk of cardiovascular disease: data from the osteoarthritis initiative","volume":"22","author":"Veronese","year":"2018","journal-title":"Journal of Nutrition, Health, and Aging"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0292|cit292","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42358-021-00186-4","article-title":"Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study","volume":"61","author":"Vicente","year":"2021","journal-title":"Advances in Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0293|cit293","first-page":"97","article-title":"Prolonged remission with colchicine in a case of familial Mediterranean fever","volume":"149","author":"Vilardell","year":"1978","journal-title":"Revista Clinica Espa\u00f1ola"},{"issue":"7","key":"10.1002\/14651858.CD015003.pub2-BIB0294|cit294","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40264-020-00930-7","article-title":"Evidence of clinically meaningful drug-drug interaction with concomitant use of colchicine and clarithromycin","volume":"43","author":"Villa Zapata","year":"2020","journal-title":"Drug Safety"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0295|cit295","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11739-016-1496-5","article-title":"Effect of colchicine in prevention of pericardial effusion and atrial fibrillation: a meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"International and Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015003.pub2-BIB0296|cit296","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40256-020-00408-y","article-title":"Inflammation may be the future of cardiovascular risk reduction: Does colchicine have a current Indication?","volume":"21","year":"2021","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0297|cit297","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1749-6632.1975.tb19201.x.","article-title":"Microtubules as drug receptors: pharmacological properties of microtubule protein","volume":"253","author":"Wilson","year":"1976","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0298|cit298","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD015003.pub2-BIB0299|cit299","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.amjcard.2020.10.043","article-title":"Meta-analysis evaluating the utility of colchicine in secondary prevention of coronary artery disease","volume":"140","author":"Xia","year":"2021","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD015003.pub2-BIB0300|cit300","doi-asserted-by":"publisher","first-page":"577","DOI":"10.33963\/KP.15879","article-title":"Severe cardiovascular involvement in a patient with rheumatoid arthritis","volume":"79","author":"Yalcinkaya","year":"2021","journal-title":"Kardiologia Polska"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0301|cit301","doi-asserted-by":"publisher","first-page":"100853","DOI":"10.1016\/j.cpcardiol.2021.100853","article-title":"Triggers of cardiovascular diseases in rheumatoid arthritis","volume":"47","author":"Zhang","year":"2022","journal-title":"Current Problems in Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD015003.pub2-BIB0302|cit302","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-020-08831-4","article-title":"Clinical treatment options in scleroderma: recommendations and comprehensive review","volume":"62","author":"Zhao","year":"2022","journal-title":"Clinical Reviews in Allergy and Immunology"},{"issue":"3","key":"10.1002\/14651858.CD015003.pub2-BIB0303|cit303","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"issue":"6","key":"10.1002\/14651858.CD015003.pub2-BIB0304|cit304","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015003","article-title":"Colchicine for the primary prevention of cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:04:03Z","timestamp":1776247443000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015003.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":304,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015003.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}